The Scientist

» clinical trials and disease/medicine

Most Recent

image: Repurposing Existing Drugs for New Indications

Repurposing Existing Drugs for New Indications

By | January 1, 2017

An entire industry has sprung up around resurrecting failed drugs and recycling existing compounds for novel indications.

1 Comment

image: Infographic: Repurposing Strategies

Infographic: Repurposing Strategies

By | January 1, 2017

Novel uses for existing and failed drugs may save companies time and money in bringing new therapeutics to market.

0 Comments

Oncologists have raised concerns about a mouse study that suggests the vaccine for human papillomavirus could cause brain damage.

0 Comments

New approaches to treating cancer have shown great promise, but they also come with serious risks that give us cause for concern.

1 Comment

image: FDA OKs Clinical Trials of Ecstasy for PTSD

FDA OKs Clinical Trials of Ecstasy for PTSD

By | December 1, 2016

The illicit drug has shown promise in helping people with debilitating post-traumatic stress disorder.

0 Comments

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

image: Opinion: Not All Genetic Databases Are Equal

Opinion: Not All Genetic Databases Are Equal

By | December 1, 2016

Sorting out which data sets are clinical-grade is key to helping patients.

0 Comments

image: More Success Fixing Sickle Cell Gene with CRISPR

More Success Fixing Sickle Cell Gene with CRISPR

By | November 9, 2016

Researchers say they have sufficient in vitro and animal data to apply for human testing.

0 Comments

image: New Support for Experimental Alzheimer’s Drug

New Support for Experimental Alzheimer’s Drug

By | November 2, 2016

Merck’s verubecestat, which is currently being tested in two Phase 3 studies, is safe, according to newly published Phase 1 data.

2 Comments

Family members with a certain gene variant had unnecessary interventions, highlighting the potential hazards of precision medicine.

2 Comments

Popular Now

  1. Publishers’ Legal Action Advances Against Sci-Hub
  2. How Microbes May Influence Our Behavior
  3. Metabolomics Data Under Scrutiny
    Daily News Metabolomics Data Under Scrutiny

    Out of 25,000 features originally detected by metabolic profiling of E. coli, fewer than 1,000 represent unique metabolites, a study finds.

  4. Sexual Touch Promotes Early Puberty
    Daily News Sexual Touch Promotes Early Puberty

    The brains and bodies of young female rats can be accelerated into puberty by the presence of an older male or by stimulation of the genitals.

AAAS